π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
To identify the efficiency of Irinotecan, Oxaliplatin, and S1 in patients w...
Status
Completed
Location
Qingdao Central Hospital
Start Date
2018-01-26
Trial ID
NCT03726021
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of HR07080...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06383078
Treatments Being Tested
This study will attempt to determine the feasibility of combination of Oxal...
Status
Completed
Location
Hallym University Medical Center
Start Date
2012-06
Trial ID
NCT01693445
Treatments Being Tested
Pancreatic cancer represents the most lethal of the common malignancies wit...
Status
Unknown
Location
Department of Pancreatic and Hepatobiliary Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2020-07-01
Trial ID
NCT03403101
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as S-1, work in different ways ...
Status
Unknown
Location
Osaka Medical College
Start Date
2009-07
Trial ID
NCT00974389
Treatments Being Tested
This is a prospective, single arm, phase II clinical study investigating se...
Status
Not Yet Recruiting
Location
Zhongshan Hospital
Start Date
2024-01-01
Trial ID
NCT06166589
Treatments Being Tested
Patients will be treated with irinotecan (150mg/m2) followed by oxaliplatin...
Status
Completed
Location
National Cancer Center Korea
Start Date
2007-07
Trial ID
NCT00512681
Treatments Being Tested
This study aimed to evaluate the efficacy and safety of camrelizumab combin...
Status
Unknown
Location
270 Dongan Road, Fudan University Shanghai Cancer Center
Start Date
2022-01
Trial ID
NCT05193292
This phase II clinical trial will enroll patients with newly-diagnosed loca...
Status
Unknown
Location
Multiple Locations
Start Date
2017-11-01
Trial ID
NCT03316326
Treatments Being Tested
This study is an open-label, single center, and a dose-escalating phase I s...
Status
Unknown
Location
National Cancer Center Korea
Start Date
2006-09
Trial ID
NCT00506207
Treatments Being Tested